First United Bank & Trust »

Arcutis Biotherapeutics shares owned by First United Bank & Trust

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by First United Bank & Trust from 13F filings

Historical chart of First United Bank & Trust investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by First United Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by First United Bank & Trust

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.1k 150 13.93
2024-09-30 $1.4k 150 9.30
2024-06-30 $1.4k 150 9.30
2024-03-31 $1.5k 150 9.91
2023-12-31 $484 150 3.23

More positions owned by First United Bank & Trust

Invesco QQQ Unit Series 1 Unit Ser 1 (QQQ)
Vanguard Value ETF Value Etf (VTV)
Apple (AAPL)
Vanguard Growth ETF Growth Etf (VUG)
Vanguard Index FDS S&P 500 ETF S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
iShares Select Dividend ETF Select Divid Etf (DVY)
Invesco S&P 500 Equal Weight S&p500 Eql Wgt (RSP)
Invesco S&P 500 Garp ETF S&p 500 Garp Etf (SPGP)
Flexshares Stoxx US ESG Impact Index Stox Us Esg Slct (ESG)
Vanguard Index FDS McAp GR Idxvip Mcap Gr Idxvip (VOT)
Vanguard Mid-Cap ETF Mid Cap Etf (VO)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)

View all positions for First United Bank & Trust

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
Vanguard Group
Polar Capital Holdings
State Street Corporation
Franklin Resources
Gilder, Gagnon, Howe & Co
Citadel Advisors
Geode Capital Management
Ensign Peak Advisors
Cormorant Asset Management
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics